Inhaled insulin

British Medical Journal

Volumn 328, Issue 7450, 2004, Pages 1215-1216

  Amiel, Stephanie A ^a   George, K ^b   Alberti, M M ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

ASTHMA; DIABETES MELLITUS; DRUG BIOAVAILABILITY; DRUG DOSE REGIMEN; DRUG EFFICACY; EDITORIAL; GLYCEMIC INDEX; HUMAN; HYPERGLYCEMIA; INJECTION; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; PRIORITY JOURNAL; SMOKING; HYPOGLYCEMIA; INHALATIONAL DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; PATIENT SATISFACTION;

EID: 2542473415     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.328.7450.1215     Document Type: Editorial

References (13)

1. Wigley FM, Londono JH, Wood SH, Shipp JC, Waldman RH. Insulin across respiratory mucosae by aerosol delivery. Diabetes 1991;20:552-7.
2. Heinemann L, Klappoth W, Rave K, Hompesch B, Linkeschowa R, Heise T. Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer. Diabetes Care 2000;23:1343-7.
3. Kim D, Mudaliar S, Chinnapongse S, Chu N, Boies SM, Davis T, et al. Dose-response relationships of inhaled insulin delivered via the aerodose insulin inhaler and subcutaneously injected insulin in patients with type 2 diabetes. Diabetes Care 2003;26:2842-7.
4. Royle P, Waugh N, McAuley L, McIntyre L, Thomas S. Inhaled insulin in diabetes mellitus. Cochrane Database Syst Rev 2003;CD003890.
5. Weiss SR, Cheng SL, Kourides IA, Gelfand RA, Landschulz WH. Inhaled Insulin Phase II Study Group. Inhaled insulin provides improved glycemic control in patients with type 2 diabetes mellitus inadequately controlled with oral agents: a randomized controlled trial. Arch Intern Med 2003;163:2277-82.
6. Cappelleri JC, Gerber RA, Kourides IA, Gelfand RA. Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes. Diabetes Care 2000;23:1799-803.
7. Gerber RA, Cappelleri JC, Kourides IA, Gelfand RA. Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: a randomized controlled trial. Diabetes Care 2001;24:1556-9.
8. Cappelleri JC, Cefalu WT, Rosenstock J, Kourides IA, Gerber RA. Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen. Clin Ther 2002;24:552-64.
9. Himmelmann A, Jendle J, Mellen A, Petersen AH, Dahl UL, Wollmer P. The impact of smoking on inhaled insulin. Diabetes Care 2003;26:677-82.
10. Henry RR, Mudaliar SR, Howland WC 3rd, Chu N, Kim D, An B, Reinhardt RR. Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects. Diabetes Care 2003;26:764-9.
11. Selam JL. Inhaled insulin for the treatment of diabetes: projects and devies. Expert Opin Pharmacother 2003;4:1373-7.
12. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999;8:79-91.
13. Zamanini A, Newson RB, Maisey M, Feher MD. Injection related anxiety in insulin treated diabetes. Diab Res Clin Pract 1999;46:239-46.